SAM
S.A. Mason Portfolio holdings
AUM
$207M
This Quarter Return
-16.83%
1 Year Return
+19.69%
3 Year Return
+79.9%
5 Year Return
+129.78%
10 Year Return
–
AUM
$82.4M
AUM Growth
+$82.4M
(-21%)
Cap. Flow
-$2.39M
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
25.49%
Holding
473
New
20
Increased
82
Reduced
119
Closed
88
Top Buys
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$1.61M |
| 2 |
TIF
Tiffany & Co.
TIF
|
$655K |
| 3 |
Vanguard Small-Cap ETF
VB
|
$438K |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
$351K |
| 5 |
Vanguard S&P Small-Cap 600 ETF
VIOO
|
$350K |
Sector Composition
| 1 | Technology | 14.1% |
| 2 | Healthcare | 11.34% |
| 3 | Consumer Staples | 10.02% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Financials | 6.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Oracle
ORCL
$635B
| $320K | 0.39% |
6,627
+56
| +0.9% | +$2.7K |
|
77
Novartis
NVS
$245B
| $305K | 0.37% |
3,694
-132
| -3% | -$10.9K |
|
78
SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$14.2B
| $292K | 0.35% |
11,527
-3,850
| -25% | -$97.5K |
|
79
Vanguard Mid-Cap Value ETF
VOE
$18.8B
| $289K | 0.35% |
3,555
-85
| -2% | -$6.91K |
|
|
WBA
80
DELISTED
Walgreens Boots Alliance
WBA
| $289K | 0.35% |
6,310
-800
| -11% | -$36.6K |
|
81
Eli Lilly
LLY
$657B
| $285K | 0.35% |
2,051
| – | – |
|
82
Gentex
GNTX
$6.15B
| $282K | 0.34% |
12,732
-1,102
| -8% | -$24.4K |
|
83
Emerson Electric
EMR
$74.3B
| $280K | 0.34% |
5,875
-150
| -2% | -$7.15K |
|
84
Merck
MRK
$210B
| $277K | 0.34% |
3,602
-96
| -3% | -$7.38K |
|
85
Steelcase
SCS
$1.92B
| $277K | 0.34% |
28,023
+19,075
| +213% | +$189K |
|
86
Exxon Mobil
XOM
$487B
| $269K | 0.33% |
7,085
+141
| +2% | +$5.35K |
|
87
WisdomTree US MidCap Fund
EZM
$818M
| $266K | 0.32% |
10,079
| – | – |
|
88
Meta Platforms (Facebook)
META
$1.86T
| $266K | 0.32% |
1,595
-150
| -9% | -$25K |
|
89
Vanguard Total Bond Market
BND
$134B
| $265K | 0.32% |
3,100
+1,200
| +63% | +$103K |
|
90
Pfizer
PFE
$141B
| $265K | 0.32% |
8,126
-262
| -3% | -$8.54K |
|
91
Xylem
XYL
$34.5B
| $264K | 0.32% |
4,050
| – | – |
|
92
Bristol-Myers Squibb
BMY
$96B
| $263K | 0.32% |
4,723
+109
| +2% | +$6.07K |
|
93
3M
MMM
$82.8B
| $261K | 0.32% |
1,915
-80
| -4% | -$10.9K |
|
94
Labcorp
LH
$23.1B
| $253K | 0.31% |
2,000
| – | – |
|
95
Estee Lauder
EL
$33B
| $251K | 0.3% |
1,575
| – | – |
|
96
Avanos Medical
AVNS
$554M
| $230K | 0.28% |
8,552
-1,650
| -16% | -$44.4K |
|
97
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $226K | 0.27% |
6,786
-3,165
| -32% | -$105K |
|
98
Alphabet (Google) Class C
GOOG
$2.58T
| $223K | 0.27% |
192
| – | – |
|
99
Vanguard Small-Cap Growth ETF
VBK
$20.1B
| $223K | 0.27% |
1,487
-3
| -0.2% | -$450 |
|
100
Phillips 66
PSX
$54B
| $221K | 0.27% |
4,114
+500
| +14% | +$26.9K |
|